Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Prostate
Study Phase
Phase 3
Study Completion Date
December 2011
NCT00676650Uploaded 09-09-2013
Available for Download
PDS UID: Prostat_Pfizer_2008_81
A Multicenter, Randomized, Double-Blind, Phase 3 Study Of Sunitinib Plus Prednisone Versus Prednisone In Patients With Progressive Metastatic Castration-Resistant Prostate Cancer After Failure Of A Docetaxel-Based Chemotherapy Regimen
Files:
PROTOCOLPfizer Study Protocol Sunitinib.pdf
CRFPfizer CRF Sunitinib.pdf
DATA DICTIONARYPfizer Data Descriptors Sunitinib.xlsx
DATA (COMPARATOR ARM)Pfizer Data Sunitinib.zip